SCHEMBL2946483

SCHEMBL2946483

CCCCc1ccc2nc(-c3ccc(OCCOC)cc3)cn2n1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 9/20 0.47
CYP19A1 P11511 2/20 0.44
KDM4E B2RXH2 1/20 0.44
NPC1 O15118 1/20 0.44
ALDH1A1 P00352 1/20 0.44
PKM P14618 1/20 0.44
NFKB1 P19838 1/20 0.44
RAB9A P51151 1/20 0.44
NFKB2 Q00653 1/20 0.44
RELA Q04206 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
HRH2 P25021 1/20 0.40
AGER Q15109 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2953031 0.82 NPC1 (0.51) HRH3CYP19A1KDM4ENPC1ALDH1A1
SCHEMBL13236507 0.81 HRH3 (0.52) HRH3CYP19A1KDM4ENPC1ALDH1A1
SCHEMBL2952526 0.80 NPC1 (0.43) HRH3KDM4ENPC1ALDH1A1PKM
SCHEMBL2947288 0.79 RXFP1 (0.48) HRH3KDM4ENPC1ALDH1A1PKM
SCHEMBL13236495 0.75 NPC1 (0.48) HRH3CYP19A1KDM4ENPC1ALDH1A1
SCHEMBL2945335 0.74 PDE10A (0.42) HRH3KDM4ENPC1ALDH1A1PKM
SCHEMBL14528678 0.73 RAB9A (0.46) HRH3KDM4ENPC1ALDH1A1PKM
SCHEMBL14528677 0.72 NPC1 (0.38) HRH3KDM4ENPC1ALDH1A1PKM
SCHEMBL14528852 0.72 HRH3 (0.47) HRH3CYP19A1KDM4ENPC1ALDH1A1
SCHEMBL2066270 0.71 PDE10A (0.37) SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7759349-B2 Control of parasites in animals by the use of imidazo[1,2-b]pyridazine derivatives SCHERING-PLOUGH ANIMAL HEALTH CORPORATION (US) 2010-07-20 US disclosed
US-7759349-B2 Control of parasites in animals by the use of imidazo[1,2-b]pyridazine derivatives SCHERING-PLOUGH ANIMAL HEALTH CORPORATION (US) 2010-07-20 US disclosed
US-7759349-B2 Control of parasites in animals by the use of imidazo[1,2-b]pyridazine derivatives SCHERING-PLOUGH ANIMAL HEALTH CORPORATION (US) 2010-07-20 US disclosed
EP-1699799-B1 CONTROL OF PARASITES IN ANIMALS BY THE USE OF IMIDAZO [1,2-B]PYRIDAZINE DERIVATIVES SCHERING PLOUGH LTD (CH) 2007-05-16 EP disclosed
EP-1699799-A1 CONTROL OF PARASITES IN ANIMALS BY THE USE OF IMIDAZO [1,2-B]PYRIDAZINE DERIVATIVES Schering-Plough Ltd. (CH) 2006-09-13 EP disclosed
US-20050182059-A1 Control of parasites in animals by the use of imidazo[1,2-b]pyridazine derivatives SCHERING-PLOUGH ANIMAL HEALTH CORPORATION 2005-08-18 US disclosed
WO-2005066177-A1 CONTROL OF PARASITES IN ANIMALS BY THE USE OF IMIDAZO[1,2-B]PYRIDAZINE DERIVATIVES SCHERING-PLOUGH LTD. (CH) 2005-07-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050182059-A1 Control of parasites in animals by the use of imidazo[1,2-b]pyridazine derivatives PLPBP, PIR, PPIP5K2 HRH3 214/4885CYP19A1 3293/4885KDM4E 3444/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.